In preparation for the March 2020 launch of MiSight 1 day contact lenses, which has received FDA approval for slowing the progression of myopia in children ages 8 to 12, CooperVision announced the details of Brilliant Futures, its comprehensive myopia management program.
An initial group of eye care professionals learned about the program and how to prepare to prescribe the MiSight lens at a company-sponsored event in Miami, Fla., between Jan. 7 and Jan. 8. According to CooperVision, the Brilliant Futures program provides inclusive practice, child and parent support to create the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty, all through a comprehensive management program that features the MiSight lens.
The management program features a transparent, defined protocol for care, free product shipping and returns and an interactive mobile app to keep patients engaged with the practice and their program of care. Specifically, the app includes access to myopia management information, lens-handling videos, appointment scheduling and reminders, product ordering and more. For more information, visit coopervision.com/practitioner/myopia-management . OM